MR-guided, percutaneous microwave ablation of primary and secondary malignant tumors of liver and kidney

MR-guided, percutaneous microwave ablation of primary and secondary malignant tumors of liver and kidney - MR microwave

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017652

Enrollment

200

Registered

2019-07-30

Start date

2015-06-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C22.9 C64 D48.9

Interventions

Group 1: MR-guided microwave ablation of primary and secondary liver or kidney tumors

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study population includes patients undergoing MR-guided microwave ablation of primary or secondary liver or kidney tumors at the Institute of Diagnostic and Interventional Radiology (University hospital Tübingen). Inclusion criteria are the age of 18 and the patient's legal capacity to consent.

Exclusion criteria

Exclusion criteria: Exclusion criterion is the patient's missing or incomplete declaration of consent.

Design outcomes

Primary

Measure	Time frame
The aim of our prospective study is to investigate the long-term course (overall survival) of patients undergoing MR-guided microwave ablation of primary or secondary liver or kidney tumors in our department.	—

Secondary

Measure	Time frame
relapse-free survival, occurrence of local recurrences, occurrence of complications	—

Countries

Germany

Contacts

Public ContactRüdiger Hoffmann

Abteilung für Diagnostische und Interventionelle RadiologieUniversitätsklinikum Tübingen

ruediger.hoffmann@med.uni-tuebingen.de+49/7071/29-86677

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026